glp 1 agonist diabetes GLP-1 Receptor Agonists as Treatments for Type 2 GLP-1 Agonists - What is

This piece in 1993 also provided new insights into the biology of exendin, namely that exendin-4 was a full agonist of the human GLP-1 receptor, which Mojsov argues was crucial to convincing Amylin to develop exendin as a drug for diabetes (see below)

Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease

Traditional approaches to obesity management, including lifestyle interventions and older pharmacotherapies, have historically demonstrated limited long-term efficacy, creating an urgent need for more effective therapeutic options

doi: 10.3389/fendo.2022.1033479 Received 31 August 2022 Accepted 27 October 2022 Published 17 November 2022 Volume 13 - 2022 Edited by Jianbo Zhou, Beijing Tongren Hospital, Capital Medical University, China Reviewed by Finbarr P